Related Experiment Video
Updated: Apr 30, 2026

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy
Published on: December 30, 2025
Application of microRNAs in diabetes mellitus
Haiyong Chen1, Hui-Yao Lan1, Dimitrios H Roukos1
1Li Ka Sing Faculty of MedicineSchool of Chinese Medicine, The University of Hong Kong, Pok Fu Lam, Hong KongDepartment of Medicine and TherapeuticsFaculty of Medicine, Li Ka Shing Institute of Health Science, The Chinese University of Hong Kong, Shatin, Hong KongCentre for Biosystems and Genome Network MedicineIoannina University, Ioannina, GreeceDepartment of Clinical OncologyQueen Elizabeth Hospital, Kowloon, Hong Kong.
Abstract:
MicroRNAs (miRNAs) are small molecules negatively regulating gene expression by diminishing their target mRNAs. Emerging studies have shown that miRNAs play diverse roles in diabetes mellitus. Type 1 diabetes (T1D) and T2D are two major types of diabetes. T1D is characterized by a reduction in insulin release from the pancreatic β-cells, while T2D is caused by islet β-cell dysfunction in response to insulin resistance. This review describes the miRNAs that control insulin release and production by regulating cellular membrane electrical excitability (ATP:ADP ratio), insulin granule exocytosis, insulin synthesis in β-cells, and β-cell fate and islet mass formation. This review also examines miRNAs involved the insulin resistance of liver, fat, and skeletal muscle, which change insulin sensitivity pathways (insulin receptors, glucose transporter type 4, and protein kinase B pathways). This review discusses the potential application of miRNAs in diabetes, including the use of gene therapy and therapeutic compounds to recover miRNA function in diabetes, as well as the role of miRNAs as potential biomarkers for T1D and T2D.
Insights
MicroRNAs (miRNAs) regulate gene expression and are crucial in diabetes. This review explores their roles in insulin production, resistance, and potential as biomarkers for type 1 and type 2 diabetes.
Area of Science:
- Molecular Biology
- Endocrinology
- Genetics
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression post-transcriptionally.
- Diabetes mellitus, encompassing Type 1 (T1D) and Type 2 (T2D), involves complex regulatory mechanisms.
- Dysregulation of miRNAs is increasingly implicated in the pathogenesis of diabetes.
Purpose of the Study:
- To review the multifaceted roles of miRNAs in the development and progression of T1D and T2D.
- To elucidate miRNA involvement in pancreatic beta-cell function and insulin resistance.
- To discuss the therapeutic and diagnostic potential of miRNAs in diabetes management.
Main Methods:
- Literature review of studies on miRNA function in diabetes.
- Analysis of miRNA regulation of insulin synthesis, secretion, and beta-cell fate.
- Examination of miRNA impact on insulin sensitivity in peripheral tissues.
Main Results:
- miRNAs modulate beta-cell electrical excitability, insulin exocytosis, synthesis, and islet mass.
- Specific miRNAs are involved in insulin resistance pathways in the liver, fat, and skeletal muscle.
- miRNAs show promise as biomarkers for T1D and T2D and as therapeutic targets.
Conclusions:
- miRNAs are critical regulators in both beta-cell function and insulin sensitivity.
- Targeting miRNAs offers potential therapeutic strategies for diabetes.
- miRNAs represent valuable biomarkers for diabetes diagnosis and prognosis.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Diabetic Retinopathy
Diabetes Mellitus: Introduction
Type I Diabetes II: Pathophysiology

